About PAT complex subunit CCDC47
PAT complex subunit CCDC47 (CCDC47) is a protein
from Homo sapiens identified by UniProt accession
Q96A33, 483 residues long.
MolForge cross-references it against 0 known binders and
53 disease associations.
Target properties
| Protein name | PAT complex subunit CCDC47 |
| UniProt accession | Q96A33 |
| Gene | CCDC47 |
| Organism | Homo sapiens |
| Length | 483 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (53)
Diseases linked to this target (Open Targets).
- trichohepatoneurodevelopmental syndrome · score 0.67
- Woolly hair · score 0.37
- Abnormality of the liver · score 0.37
- Global developmental delay · score 0.37
- Intellectual disability · score 0.37
- body height · score 0.17
- body fat percentage · score 0.17
- IGF-1 measurement · score 0.16
- PR interval · score 0.13
- BMI-adjusted waist circumference · score 0.12
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96A33-F1 | alphafold | PREDICTED | 76.83 | — |
Amino-acid sequence (483 residues)
MKAFHTFCVV LLVFGSVSEA KFDDFEDEED IVEYDDNDFA EFEDVMEDSV TESPQRVIIT EDDEDETTVE LEGQDENQEG DFEDADTQEG DTESEPYDDE EFEGYEDKPD TSSSKNKDPI TIVDVPAHLQ NSWESYYLEI LMVTGLLAYI MNYIIGKNKN SRLAQAWFNT HRELLESNFT LVGDDGTNKE ATSTGKLNQE NEHIYNLWCS GRVCCEGMLI QLRFLKRQDL LNVLARMMRP VSDQVQIKVT MNDEDMDTYV FAVGTRKALV RLQKEMQDLS EFCSDKPKSG AKYGLPDSLA ILSEMGEVTD GMMDTKMVHF LTHYADKIES VHFSDQFSGP KIMQEEGQPL KLPDTKRTLL FTFNVPGSGN TYPKDMEALL PLMNMVIYSI DKAKKFRLNR EGKQKADKNR ARVEENFLKL THVQRQEAAQ SRREEKKRAE KERIMNEEDP EKQRRLEEAA LRREQKKLEK KQMKMKQIKV KAM
Explore PAT complex subunit CCDC47 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets